Inhibition of Lysosome Membrane Recycling Causes Accumulation of Gangliosides that Contribute to Neurodegeneration
Maxime Boutry,
Julien Branchu,
Céline Lustremant,
Claire Pujol,
Julie Pernelle,
Raphaël Matusiak,
Alexandre Seyer,
Marion Poirel,
Emeline Chu-Van,
Alexandre Pierga,
Kostantin Dobrenis,
Jean-Philippe Puech,
Catherine Caillaud,
Alexandra Durr,
Alexis Brice,
Benoit Colsch,
Fanny Mochel,
Khalid Hamid El Hachimi,
Giovanni Stevanin,
Frédéric Darios
Affiliations
Maxime Boutry
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; Ecole Pratique des Hautes Etudes, PSL Research University, Laboratoire de Neurogénétique, F-75013 Paris, France
Julien Branchu
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Céline Lustremant
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Claire Pujol
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Julie Pernelle
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Raphaël Matusiak
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Alexandre Seyer
Profilomic SA, F-92100 Boulogne-Billancourt, France
Marion Poirel
Profilomic SA, F-92100 Boulogne-Billancourt, France
Emeline Chu-Van
Service de Pharmacologie et d’Immunoanalyse (SPI), Laboratoire d’Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France
Alexandre Pierga
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Kostantin Dobrenis
Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Jean-Philippe Puech
Laboratoire de Biochimie Métabolomique et Protéomique, Hôpital Universitaire Necker-Enfants Malades, AP-HP, F-75015 Paris, France
Catherine Caillaud
Laboratoire de Biochimie Métabolomique et Protéomique, Hôpital Universitaire Necker-Enfants Malades, AP-HP, F-75015 Paris, France
Alexandra Durr
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; National Reference Center for Neurogenetic Diseases, Pitié-Salpêtrière University Hospital, APHP, F-75013 Paris, France
Alexis Brice
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France
Benoit Colsch
Service de Pharmacologie et d’Immunoanalyse (SPI), Laboratoire d’Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France
Fanny Mochel
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; National Reference Center for Neurogenetic Diseases, Pitié-Salpêtrière University Hospital, APHP, F-75013 Paris, France; Bioclinic and Genetic Unit of Neurometabolic Diseases, Pitié-Salpêtrière University Hospital, F-75013 Paris, France
Khalid Hamid El Hachimi
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; Ecole Pratique des Hautes Etudes, PSL Research University, Laboratoire de Neurogénétique, F-75013 Paris, France
Giovanni Stevanin
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; Ecole Pratique des Hautes Etudes, PSL Research University, Laboratoire de Neurogénétique, F-75013 Paris, France; National Reference Center for Neurogenetic Diseases, Pitié-Salpêtrière University Hospital, APHP, F-75013 Paris, France; Corresponding author
Frédéric Darios
Sorbonne Université, F-75013 Paris, France; Inserm, U1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), F-75013 Paris, France; Corresponding author
Summary: Lysosome membrane recycling occurs at the end of the autophagic pathway and requires proteins that are mostly encoded by genes mutated in neurodegenerative diseases. However, its implication in neuronal death is still unclear. Here, we show that spatacsin, which is required for lysosome recycling and whose loss of function leads to hereditary spastic paraplegia 11 (SPG11), promotes clearance of gangliosides from lysosomes in mouse and human SPG11 models. We demonstrate that spatacsin acts downstream of clathrin and recruits dynamin to allow lysosome membrane recycling and clearance of gangliosides from lysosomes. Gangliosides contributed to the accumulation of autophagy markers in lysosomes and to neuronal death. In contrast, decreasing ganglioside synthesis prevented neurodegeneration and improved motor phenotype in a SPG11 zebrafish model. Our work reveals how inhibition of lysosome membrane recycling leads to the deleterious accumulation of gangliosides, linking lysosome recycling to neurodegeneration. : Boutry et al. show that inhibition of lysosome membrane recycling leads to lysosomal accumulation of some glycosphingolipids (simple gangliosides), which contributes to neuronal death. Keywords: lipid metabolism, lysosomes, membrane trafficking, neurodegenerative disease, glycosphingolipids, autophagic lysosome recovery, autophagy, induced pluripotent stem cells, organoids, knockout